drugset / Trial / NCT00308737
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
Pulmonary Safety in Diabetics with T/I
Timeline
- Start
- 2005-06
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 15 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 30 iu | Inhaled |